CONSONANCE CAPITAL MANAGEMENT LP

Company

Vanda Pharmaceuticals Inc.

Filed

February 14, 2019

Accession Number

0001085146-19-000752

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →